Marra, Carbohydrate Research 187, 35-42, 1989.* |
Davies et al., “NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects,” Aliment Pharmacol Ther., 11:69-79, 1997. |
Frassen et al., “Low Molecular Weight Proteins as Carriers for Renal Drug Targeting. Preparation of Drug-Protein Conjugates and Drug-Spacer Derivatives as Their Catabolism in Renal Cortex Homogenates and Lysosomal Lysates,” J. Med. Chem., 35:1246-1259, 1992. |
David Y. Graham, M.D., M.A.C.G., “Nonsteroidal Anti-Inflammatory Drugs, Helicobacter pylori, and Ulcers: Where We Stand,” The American Journal of Gasroenterology, 91/10:2080-2086, 1996. |
Möller et al., “Novel 5-aminosalicylic acid NSAID conjugates: synthesis; pharmacological and toxicological properties,” Eur. J. Med. Chem., 24:463-469, 1989. |
Rautio et al., “Synthesis and In Vitro Evaluation of Aminoacyloxyalkyl Esters of 2-(6-methoxy-2-naphthyl) propionic Acid as Novel Naproxen Prodrugs for Dermal Drug Delivery,” Pharmaceutical Research, 16/8:1172-1178, 1999. |
Shanbhag et al., “Ester and Amide Prodrugs of Iburprofen and Naproxen: Synthesis, Anti-inflammatory Activity, and Gastrointestinal Toxicity,” Journal of Pharmaceutical Sciences, 81/2:149-154, 1992. |
Tammara et al., “Synthesis and Evaluation of Morpholinoalkyl Ester Prodrugs of Indomethacin and Naproxen,” Pharmaceutical Research, 10/8:1191-1199, 1993. |
Venuti et al., “Synthesis and Biological Evaluation of Ω-(N,N,N,-Trialkylammonium)alkyl Esters and Thioesters of Carboxylic Acid Nonsteroidal Antiinflammatory Agents,” Pharmaceutical Research, 6:10:867-873, 1989. |